Marksans Pharma Ltd
BSE:
NSE:MARKSANS
MARKSANS Share Price
BSE:
NSE:MARKSANS
Pharmaceuticals
Mid Cap
₹-
0 (0%)
Market Cap
₹11,791.32Cr
PE Ratio
33.97
Marksans Pharma Ltd Performance
▲
▲
▲
▲
Marksans Pharma Ltd Fundamentals
Marksans Pharma Ltd Delivery and Volume
About Marksans Pharma Ltd
Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982. Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited with effect from 10th October, 2005. The Company primarily engaged in
| Name | Designation |
|---|---|
| Mark Saldanha | Chairman & Managing Director |
| Harshavardhan Panigrahi | Company Sec. & Compli. Officer |
| Seetharama Raju Buddharaju | Non-Exec. & Independent Dir. |
| Sandra Saldanha | Whole-time Director |
| Digant Mahesh Parikh | Non-Exec. & Independent Dir. |
| Varddhman Vikramaditya Jain | Whole-time Director |
| Abhinna Sundar Mohanty | Non-Exec. & Independent Dir. |
| Sunny Sharma | Non Executive Director |
| Shailaja Vardhan | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Marksans Pharma Ltd FAQs
How do I Buy Marksans Pharma Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Marksans Pharma Ltd shares in BlinkX.
What is the Share Price of Marksans Pharma Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Marksans Pharma Ltd's share price is ₹260.5 as of 2025-01-13.
What is the PE ratio of Marksans Pharma Ltd?
Marksans Pharma Ltd's P/E ratio is 33.97 times as of 2025-01-13.
What is the PB ratio of Marksans Pharma Ltd?
Marksans Pharma Ltd's most recent financial reports indicate a price-to-book ratio of 5.17, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Marksans Pharma Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Marksans Pharma Ltd's market capitalization is ₹11791.32 Cr as on 2025-01-13.
What is the ROE of Marksans Pharma Ltd?
The current financial records of Marksans Pharma Ltd show a 11.46% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Marksans Pharma Ltd?
According to Marksans Pharma Ltd's most recent financial filings, the company has a total asset value of ₹922.71, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Marksans Pharma Ltd?
The 52-week high/low price of a Marksans Pharma Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Marksans Pharma Ltd's 52-week high and low as of 2025-01-13 are ₹274 and ₹259.5, respectively.
